Blog

Eagle Genomics has landed a prestigious co-sell partnership with Microsoft for their knowledge discovery platform. The deal will see the UKI2S-supported company gain access to global enterprise leaders through the Microsoft sales team. The announcement comes on the back of the company’s successful graduation from the Microsoft ScaleUp programme, previously known as the Microsoft Accelerator. […]

read more

UKI2S biotech company CellCentric, University of Cambridge spinout, has raised $26m to fund clinical testing of its first-in-class oncology drug candidate, CCS1477. CellCentric focuses on treating prostate cancer, as well as multiple other cancers. Their new drug candidate addresses the large and increasing population of patients – upwards of 80,000 people each year — who […]

read more

1 2 3 22